Ipsen gets Bylvay FDA approval for cholestatic pruritus in Alagille syndrome

The US Food and Drug Administration (FDA) has granted approval to French biopharmaceutical company Ipsen for Bylvay (odevixibat) for the treatment of cholestatic pruritus in ... Read More